Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$307,408,715
+$234,380,354 QoQ
Shares Held
3,266,136
+341.7% QoQ
Ownership
1.63%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 98.41892682974623.ToString("F0")%
None 1.58107317025378.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. INCY ranks #17 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $307,408,715 | 3,266,136 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $73,028,361 | 739,378 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,788,133 | 21,084 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,166,405 | 75,865 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,897,223 | 80,879 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,418,522 | 136,362 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,741,352 | 71,730 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,598,072 | 174,828 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,913,816 | 138,912 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,266,240 | 131,649 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $5,112,009 | 88,489 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,812,920 | 77,316 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $19,444,383 | 269,052 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $623,055,329 | 7,757,163 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $687,886,465 | 10,322,426 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $771,433,640 | 10,154,451 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $741,639,205 | 9,338,192 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $661,223,238 | 9,008,491 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $674,396,220 | 9,805,121 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $980,104,146 | 11,649,877 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,052,383,104 | 12,949,220 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,174,227,909 | 13,499,976 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,266,847,013 | 14,116,860 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,399,966,443 | 13,465,100 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $974,518,692 | 13,307,643 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||